Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease


Deligezer U. , Yaman F., Darendeliler E. , Dizdar Y., Holdenrieder S., Kovancilar M., ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.411, ss.1452-1456, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 411
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1016/j.cca.2010.05.040
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Sayfa Sayıları: ss.1452-1456

Özet

Background: We evaluated the utility of post-treatment plasma levels of the circulating bone-morphogenetic protein-6-specific mRNA (cBMP6 mRNA), cell-free DNA (cf-DNA), apoptotic nucleosomes and Histone H3 lysine 27 trimethylation (H3K27me3), in discriminating metastatic prostate cancer (PCa) from organ confined, locally controlled disease.